N. Senda

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population

N. Shinkura, S. Ogawa, M. Kataoka, 2021, Cancer science.

Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers

T. Katagiri, E. Tokunaga, S. Ogawa, 2022, Cancer medicine.

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants

S. Miyano, Y. Shiraishi, K. Chiba, 2020, Communications Biology.

Genetic and clinical landscape of breast cancers with germline BRCA1/2 variants

S. Miyano, Y. Shiraishi, K. Chiba, 2020, Communications biology.

Long-term results of transarterial infusion chemotherapy containing Cysplatin for stage IV breast cancer

Y. Matsutani, T. Nakajima, S. Nishimura, 2010, Tenri Medical Bulletin.

Pertuzumab, trastuzumab and docetaxel reduced the recurrence of brain metastasis from breast cancer: a case report

S. Tsuyuki, A. Yamaguchi, N. Senda, 2016, Breast Cancer.

Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group

Takashi Inamoto, Akira Yamauchi, H. Kato, 2016, Breast Cancer Research and Treatment.

In silico analysis‐based identification of the target residue of integrin α6 for metastasis inhibition of basal‐like breast cancer

J. Itou, F. Sato, A. Sehara-Fujisawa, 2019, Genes to cells : devoted to molecular & cellular mechanisms.